Liu Chenginsider trades

In SEC Form 4 filings, Liu Cheng is listed as CEO of Estrella Immunopharma, Inc. (ESLA). Liu Cheng reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Aug 26.

Companies and roles

Company	Role	Transactions	Last filed
ESLAEstrella Immunopharma, Inc.	CEO	2	Aug 26

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-26

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ESLAEstrella Immunopharma, Inc.	Aug 25	Aug 26	M	100,000	$0.82	$81,500	397,437	No	Form 4
ESLAEstrella Immunopharma, Inc.	Aug 25	Aug 26	M · derivative	100,000	$0.82	$81,500	900,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.